Gene Modified CAR-T Cellular Therapy for Hematologic Malignancies

With advances in the understanding of characteristics of molecules, specific antigens on the surface of hematological malignant cells were identified and multiple therapies targeting these antigens as neoplasm treatments were developed. Among them, chimeric antigen receptor (CAR) T-cell therapy, whi...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Wen-Ying, Wang, Hsin-Hui, Chen, Yi-Wei, Lin, Chun-Fu, Fan, Hueng-Chuen, Lee, Yi-Yen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7697548/
https://www.ncbi.nlm.nih.gov/pubmed/33212810
http://dx.doi.org/10.3390/ijms21228655

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7697548/
https://www.ncbi.nlm.nih.gov/pubmed/33212810
http://dx.doi.org/10.3390/ijms21228655

Ejemplares similares